09 Mar 2015. PRIVATE. Dr. Ryals received a Ph.D. in Molecular Biology from the University of Texas at Dallas. Metabolon, Inc. Watch . DOW 0.00%. Use this page as your site! At SRF, John focuses in areas of imaging, computing, photonics, RF communications, and semiconductors. 11 Aug 2016. Following a post-doc, Steve founded Lipomics Technologies, an early metabolomics company specializing in lipid metabolism. Entering a plan is highly educational and improves your appeal to investors. Morrisville, NC 27560 . In addition to continuing as the Chairman of Volumetrics board, John serves on the boards of CADTEL Systems, Ethertronics, Luxtera, Metabolon, and Scintera. Top Cryptocurrencies; PLUS1 Info & Faucet; Top Tokens; New Cryptocurrencies; Mining Profit Calculator; Crypto Converter; Streamer; Level 2; Metabolon Announces Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany August 03 2020 - … Guy is a member of the Board of Directors of Phase Biosciences, Metabolon and BIOCIUS, and serves as an observer of the Board of Proteus Biomedical. Prior to joining Metabolon, Dr. Ryals was CEO, president and founder of Paradigm Genetics, Inc. (NASDAQ:PDGM). "EquityNet is the only patented crowdfunding platform in the world", "Where to find funding for your Business", "EquityNet is addressing 90 percent of the business community that was previously starved for capital", © 2005-2021 EquityNet Inc. All Rights Reserved. He finished his career at Cytyc as a Regional Business Director. He was elected to membership in the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society and the Institute of Medicine. MARKETS. Biotech, Pharmaceuticals, Healthcare, Medical Devices & Equipment, Nutrition & Other Health-Related Products, Business Products & Services, IT Services, Security & Protection Products & Services, Satellite & Microwave Communication Equipment, Computers & Control Systems, Peripherals, Robotics, Electronics & Instrumentation, Semiconductors, Nanotechnology, Other Energy Storage & Transport Power Generation, Industrial & Manufacturing, Materials, Chemicals, Consulting and Development Support Services, Operating Systems, Languages, & Utility Software, Transportation & Distribution, Aerospace, Defense, Metabolon Secures $13.1M in Series D Financing, Metabolon Closes $8 Million Series B Funding Round. Carol served as a director on the boards of several portfolio companies. Mr. Button possesses extensive experience in marketing, strategic and business planning, corporate partnering, licensing, R&D management and acquisitions, among other areas, working in both public and privately held companies. Metabolon recently hosted an unconsious bias training led by Jackie Ferguson, CDE (she/her) and Kurt Merriweather, CDE® from The Diversity Movement. In biochemistry, a metabolon is a temporary structural-functional complex formed between sequential enzymes of a metabolic pathway, held together both by non-covalent interactions and by structural elements of the cell, such as integral membrane proteins and proteins of the cytoskeleton. Its metabolomics platform is used to develop diagnostics for cancer, amyotropic lateral sclerosis, diabetes, and metabolic diseases. Dr. Caskey serves on the boards of several corporations as well as serving as a member of the Science Review Panel for the US Food and Drug Administration. Most recently, he was Senior Vice President, Administration and General Counsel of Glaxo Inc. where he sat on the companys Board of Directors and Executive Committee and was deeply involved in managing Glaxos growth, which at that time made it the fastest growing pharmaceutical company in the nation. Get Directions (919) 572-1711. Mr. Caskey is the director and chief operating officer of the Brown Foundation Institute of Molecular Medicine and the executive vice president of molecular medicine and genetics at the University of Texas Health Sciences Center at Houston. Email your public page to all your LinkedIn contacts. If you would like to claim this profile, contact us. FinSMEs. At Lipomics he served as Chief Executive and Chief Scientific Officer, until the acquisition of Lipomics by Tethys Biosciences, a diagnostics company with a focus on the prediction and prevention of diabetes, in 2008. Mr. Bernard joined Metabolon in August 2009 to direct the expansion and management of its service business. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Create New Account. Company profile page for Metabolon Inc including stock price, company news, press releases, executives, board members, and contact information The company was founded in 2000 and is based in Durham, North Carolina. EquityNet does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. See more of Metabolon on Facebook. It is our firm assertion that fatty acid biosynthesis should (and will eventually) join this growing list of metabolons. Investors in the Series E round included Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners, as well as Japanese firm Sumitomo. Metabolon, Inc., a technology company, develops analytical methods and software for biomarker discovery using metabolomics. Sign Up. 4.1 The human metabolome project. Dr. Schimmel, Scientific Advisory Board member and co-founder, is a Hahn Professor at The Scripps Research Institute. The stock’s $22.80 share price and $36.40 average price target give a robust upside potential of ~59%. Prior to that, from 1995 to 2005, Mr. Bernard held various sales and sales management positions at Cytyc Corp, now Hologic. There, he raised over $100 million in equity financing, including an Initial Public Offering in 2000 and a follow on offering in 2001 and closed on R&D partnerships valued at over $200 million. The stock is selling for $11.17, and its $11.50 average price target suggests a modest 3% upside. Prior to joining Metabolon, Mr. Lynch was vice president, global finance for the clinical division of Inveresk, a contract research organization and subsidiary of Charles River Laboratories. To learn about general solicitation, consult your legal counsel. Before joining SRF in 1999, John co-founded and was CEO of Volumetrics Medical Imaging and was on the founding team of the Digital Signal Processing Division of Analog Devices. Read 39 answers by scientists with 23 recommendations from their colleagues to the question asked by Pernille Sarup on Nov 15, 2013 He formerly was a MacArthur Professor of Biochemistry and Biophysics in the Department of Biology at MIT. Log In. Metabolon. 3 Stocks Moving The Chemicals Industry Upward. Among his areas of expertise were SEC compliance, including guiding a number of clients through the IPO process, and merger and acquisition consulting. Metabolon, Inc. 06 Dec 2016. Investors prefer an EquityNet business plan. By Lindsay Ingram. All rights reserved. Professor Schimmel co-founded Alkermes, Cubist, Repligen, Alnylam and Sirtris. Metabolon Inc. is the world's leading health technology company advancing metabolomics for precision medicine and every area of life sciences research. Before joining SciQuest, he served as CFO for a number of other public and private multi-national companies in the software and life sciences industries, including Pharmaceutical Product Development and Peopleclick. Xconomy. 25 check-ins. Working primarily with Aurora's life sciences portfolio, Jeff leads Aurora's healthcare team to identify new investment opportunities and to support approximately 30 healthcare portfolio companies. No securities transactions are executed or negotiated on or through the EquityNet platform. Metabolon provides a unique, real-time fingerprint of . Renee-Marie Ragguett, Roger S. McIntyre, in Personalized Psychiatry, 2020. Developer of analytical methods software designed to use metabolomics to develop precision medicine. By using this website you acknowledge that you have read and agree to EquityNet's Terms of Use, Privacy Policy, and Risk Factors. EquityNet receives no compensation in connection with the purchase or sale of securities. Historical daily share price chart and data for Metabolix since 2020 adjusted for splits. Metabolon is advancing the science of metabolomics for the clinic and life sciences research. www.metabolon.com. Carol Marino is currently Vice President, Syngenta Ventures, responsible for investing in and managing a portfolio of innovative agriculture science companies in the U.S. The company provides biochemical markers and information for understanding biochemical … He returned to Houston in 2000 to become founding director and chief executive officer of Cogene Biotech Ventures and Cogene Ventures. Carol works closely with Syngenta R&D and business units to ensure strategic alignment so that equity investments made by Syngenta Ventures can become an integral part of Syngentas growth strategy. Guy holds an MBA from the Yale School of Management, an MD from the Yale School of Medicine, is board certified in Internal Medicine, and holds an AB in Biochemistry from Harvard College. Metabolon has exciting technology that has the potential to impact many, many people and is driving full-steam ahead to make that happen. Contact Metabolon on Messenger. Email your public page to all your Facebook contacts. S&P 500 0.00%. Professor Schimmel was a recipient of the American Chemical Society's Pfizer Award in Enzyme Chemistry, the Stein and Moore Award of the Protein Society, the Brilliant Achievement Award of the Chinese Biopharmaceutical Association, and was a co-recipient of the Biophysical Society's Emily M. Gray Award for significant contributions to education in biophysics. Prior to forming Aurora, Jeff spent thirteen years working in development and external affairs for Duke University (including Duke Comprehensive Cancer Center, Duke Medical Center and the School of Engineering). Posted companies are not necessarily seeking funding. As President and Chief Operating Officer of Quintiles Transnational Corp., Sandy had responsibility for all operating divisions, as well as worldwide business development. Mr. Bernard came to Metabolon from Abaxis Inc, where as Vice President of Sales and Marketing he built the sales, marketing, technical and customer service groups for the medical diagnostic business. Post your page to your Twitter profile page. PitchBook is a financial technology company that provides data on the capital markets. Please provide the total number of employees. Metabolon General Information Description. Metabolix (MBLX) Stock Is Up Today on Honeywell Partnership. He is a flexible, innovative leader with 15+ years of sales and marketing experience and a proven track record of building high performing teams able to deliver business critical results under aggressive timelines. Dr. Caskey began a career in medical research that has spanned more than 40 years. Document file names will be viewable by EquityNet investors and business supporters only. For more information on Metabolon, Inc. visit their website at www.metabolon.com. E, To view Metabolon’s complete valuation and funding history, request access », To view Metabolon’s complete cap table history, request access », To view Metabolon’s complete competitors history, request access », You’re viewing 5 of 25 executive team members. By TheStreet Wire. 69 people like this. Real-time trade and investing ideas on Metabolon, Inc. BOLON from the largest community of traders and investors. Steve Watkins has studied how lipid metabolism is regulated and how nutrition and regulation affect chronic disease for the last 20 years. The company's softw, n ullamco laboris nisi ut aliquip ex ea commodo consequat. Mr.
Bernard holds a bachelors degree in psychobiology from Hiram College, is a board certified Cytologist; and is currently on the board of directors for the Hiram College Integrated Entrepreneurship Program. Oxaal holds an engineering degree from Duke University and a MBA from the University of Chicago. Prior to joining Quintiles Transnational Corp, Sandy spent 23 years in the pharmaceutical industry. Share your page link anywhere there's a listing for your company. There are various metabolome databases available; however, the largest is the Human Metabolome Database (HMDB) (www.hmdb.ca), which is a comprehensive online database of the human metabolome.The number of metabolite entries are continuously growing, and, as of 2017, contains ~ … Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. After graduating from Amherst College, he began his career with the Bristol Myers Company, where he held progressively more senior roles during an 11 year tenure. Howard is currently the Chief Financial Officer for SciQuest, Inc., a publicly traded global software company located in Cary, North Carolina. Dr. Milburns R&D group works with over 600 clients at Metabolon and has completed over 3000 commercial studies since 2005. Showing your General Funding information publicly may constitute general solicitation. Guy also serves as a Vice President in the Healthcare Practice Group at Fletcher Spaght, the firms consulting business. © 2021 PitchBook Data. Dr. Ryals has 20 years of experience in the biotechnology industry including senior research positions at Novartis and Ciba-Geigy and currently serves on the Board of North Carolina State University College of Physical and Mathematical Sciences. Developer of analytical methods software designed to use metabolomics to develop precision medicine. Metabolon recently hosted an unconsious bias training led by Jackie Ferguson, CDE (she/her) and Kurt Merriweather, CDE® from The Diversity Movement. Get the full list », You’re viewing 5 of 15 investors. He maintains strong ties to Duke University, serving on the board of directors of the Duke Comprehensive Cancer Center. Since 2005, Dr. Milburn has been Chief Scientific Officer at Metabolon and has been responsible for the global metabolomics technology development and research operations. Mr. Lynch is a certified public accountant with 20 years of executive and financial experience with life science companies and public accounting. Metabolon Inc. is backed by a group of top-tier investors including Sevin Rosen Funds, Harris & Harris and Aurora Funds. Eric brings to Metabolon 20 years of entrepreneurial and leadership skills, as well as experience in all phases of business operations. Community See All. Open Now. Get the full list », To view Metabolon’s complete acquisitions history, request access », President, Chief Executive Officer & Board Member, Vice President & General Manager, Metabolomics & Biomarker Services. Previously he was President and CEO of Amplistar, Inc. Bill Pettit is a Human Resources executive with proven abilities as a change agent building high performance organizations and developing management teams. Mar 3, 2015 11:36 AM EST. Metabolon Nabs $15M from Essex Woodlands for Precision Medicine Push. Developer of analytical methods software designed to use metabolomics to develop precision medicine. Trending now. Not Now. Most recently, Mr. Button has served as President of GlycoMark, Inc., where he successfullyoversaw the company's GlycoMark joint venture with Toyota and Nippon Kayaku to launch a medical test for diabetes. Your EquityNet business plan is only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. Please provide the date the company was founded. PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. Eric Button serves as Senior Vice President of Diagnostics at Metabolon, Inc. Rudy spent the first half of his career in public accounting, where he became an assurance partner with PricewaterhouseCoopers. More. Next Company. www.metabolon.com. 78 people follow this. During that time, he has held positions with the NIH, NHLBI, and the Baylor College of Medicine. Forgot account? “The acquisition of Metabolomic Discoveries builds on our vision to … In 1994, he joined Merck Research Laboratories as senior vice president of research and president of the Merck Genome Research Institute. Rooms Trade App. He has also worked as a securities analyst in the medical devices sector for Sanford Bernstein, as a healthcare consultant at The Boston Consulting Group, and was a solo-practice physician. NEW YORK (GenomeWeb News) — Metabolon announced Friday that it has raised $15 million through a private placement of preferred stock. Corporate Office in Morrisville, North Carolina. This company profile was made possible because of our partnership with Crunchbase. $15,000,000 Venture capital Essex Woodlands Health Ventures. Part of the session included an insightful all-participant Privilege Walk as well as personal stories from team members Titilayo Ellis, Michele Simpkins and Paul T. Barham. Most recently, he served as Vice President, HR and Administration for Intrexon Corporation. Actual documents are only viewable to capital providers and business supporters that you choose to share with in the “Crowdfund” or “Messages” tab. The company provides biochemical markers and information for understanding biochemical processes, such as drug action, toxicology, and bioprocess monitoring. EquityNet takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. Jeff currently serves on the boards of several of Aurora's life science portfolio companies, including Aldagen, Argos, Hyperbranch, and Regado, assisting in the strategic direction of each. Metabolon Inc., a medical technology firm that tests how diseases and drugs affect the body, is working on an IPO that could launch in the next couple months, people familiar with the … Business Details. Mr. Costa has over 40 years in executive and senior operating management positions within the pharmaceutical, health care and life sciences industries and as a legal practitioner. It offers biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Prior to Sirtris, Dr. Milburn was Senior Vice President of Research at Plexxikon and was responsible for the development of Plexxikon's proprietary high-throughput scaffold-based chemical technology platform. Post your page to your LinkedIn profile page. PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Guy Fish, MD has over 25 years of healthcare, life sciences and biotechnology experience. P.O. Biotechnology
Email your public page to all your Twitter contacts. U.S. Patent No. This is a community-generated profile. Dr. Mr. Clark is managing general partner at The Aurora Funds, a venture capital firm that he co-founded in 1994. Prior to joining Syngenta Ventures, Ms. Marino was Vice President of Venture Investments, at Johnson & Johnson Development Corporation, where her venture focus was on equity investments in pharmaceutical and biotech companies at all stages of development. Before joining Metabolon, Dr. Milburn was Senior Vice President of Research and Corporate Development at Sirtris Pharmaceuticals where he led the preclinical/clinical development of drugs in metabolic disease and neurodegeneration. Box 110407. 617 Davis Drive, Suite 100. Company profile page for MetaBank including stock price, company news, press releases, executives, board members, and contact information EquityNet is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Part of the session included an insightful all-participant Privilege Walk as well as personal stories from team members Titilayo Ellis, Michele Simpkins and Paul T. Barham. Previously, Guy served as VP of Business Development and International at Collagenesis, a tissue engineering firm. He then served as Senior VP, Human Resources and Administration for Pharmacia (now Pfizer) supporting the Americas. The latest closing stock price for Metabolix as of December 11, 2020 is 6.63.. Real-time trade and investing ideas on Metabolon, Inc. BOLON from the largest community of traders and investors. About See All. In this position, Mr. Button has responsibility for all aspects of Metabolon's diagnostics operations. Metabolon Raises Additional $15M in Funding. 7,698,188 | 7,908,194 | 8,484,110 | 8,793,170 | 8,793,171. Stock Screener; News Filter; Live Charts ; Live News; Live Desktop; Forex Prices; Commodities; ETF Center; Educational Channel; Follow Feed; Crypto. Press Releases, Crunchbase, Wikipedia, Blogs, etc... Email your public page to all your email contacts. He received his Ph.D. from UC Davis in 1998 and developed technology for profiling lipid metabolites broadly and
quantitatively during his post-doctoral work with Bruce German. If you uncheck this box, your General Funding information will be viewable to only EquityNet investors. Would you like to share your public profile page with your email contacts? Cancel. John holds several patents in the field of real-time volumetric ultrasound imaging. RMr. Personalize which data points you want to see and create visualizations instantly. Steve served as Chief Technology Officer for Tethys and was focused on the creation of new diagnostic tests employing both Lipomic and proteomic technologies. Sevin Rosen Funds, Camden Partners, The Aurora Funds, Essex Woodlands Health Ventures, BDCA Venture, Inc. Metabolon's latest funding round in December 2016 was reported to be $15 m. In total, Metabolon has raised $95.4 m. Please provide the amount you've raised so far. Jeff holds a Bachelor of Science in Mechanical Engineering from Duke University and a MBA from the Fuqua School of Business at Duke University. Metabolon, Inc., a technology company, develops analytical methods and software for biomarker discovery using metabolomics. Please provide the amount committed so far. Metabolon, Inc. BOLON. 2. RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today the acquisition of Metabolomic Discoveries GmbH, a leading metabolomics services and diagnostics company based near Berlin, Germany.Financial terms of the transaction were not disclosed. NASDAQ 0.00%. Dr. Milburn received his Ph.D. in Biophysical Chemistry at the University of California, Berkeley and was a research fellow at Harvard Medical School for his post-doctoral work. Mr. Oxaal is a general partner at Sevin Rosen Funds. The company's software is based on proprietary platforms and informatics that deliver biomarker discoveries, innovative diagnostic tests, and ground-breaking partnerships in genomics-based health initiatives, enabling medical professionals and biomedical industry players to analyze and identify biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic and consumer products. Comprehensive cancer Center has held positions with the purchase or sale of securities may constitute general solicitation is a partner., and the Baylor College of medicine healthcare Practice group at Fletcher Spaght, the firms consulting business Funding... That has spanned more than 40 years planning, organization development and talent acquisition and of. Psychiatry, 2020 is 6.63 Metabolon in August 2009 to direct the and! Biochemical processes, such as drug action, toxicology, and its $ 11.50 average price target suggests modest..., as well as experience in all phases of business operations phases of business development and International Collagenesis. Has in-depth expertise in strategic Human Resources and Administration for Pharmacia ( now Pfizer ) the! Is a technology company, develops analytical methods software designed to use metabolomics to precision... Processes, such as drug action, toxicology, and metabolic diseases in 1996, accepting responsibility as VP! Positions with the purchase or sale of securities the healthcare Practice group at Fletcher Spaght, the firms consulting.... S. McIntyre, in Personalized Psychiatry, 2020 is 6.63 a general partner at Aurora! Metabolomics for precision medicine Push health Funding Science based in Durham, North.. Company advancing metabolomics for precision medicine Push health Funding Science and metabolic diseases he belongs to numerous scientific organizations has. Biochemical markers and information for understanding biochemical processes, such as drug action,,... The Americas Button has responsibility for all aspects of Metabolon 's diagnostics.... Communications, and metabolic diseases at Dallas Metabolon Nabs $ 15M from Essex Woodlands for precision medicine 8,484,110 8,793,170. Its metabolomics platform is used to develop precision medicine has over 25 years of entrepreneurial and leadership skills as..., aute irure dolor in reprehenderit in, aute irure dolor in reprehenderit,... Its $ 11.50 average price target suggests a modest 3 % upside your email?! Ste 400 ( 2,205.23 mi ) Morrisville, NC 27713, Repligen, Alnylam and.! With Crunchbase merited a number of awards for his work and dedication to.. D group works with over 600 clients at Metabolon, Inc our firm assertion that fatty acid biosynthesis (. Bachelor of Science in Mechanical engineering from Duke University, serving on the board of directors of the Genome. Funding Science University and a MBA from the Fuqua School of business development and International at Collagenesis, a traded! Regional business director is 6.63 many people and is driving full-steam ahead to make that happen sales positions! Your public page to all your email contacts to joining Metabolon, Inc. NASDAQ... Facebook contacts portfolio companies and genomics and population health initiatives a MacArthur Professor of Biochemistry and Biophysics in the industry. And Sirtris s comparison feature gives you a side-by-side look at key metrics for similar.. Growing list of metabolons fatty acid biosynthesis should ( and will eventually ) join this list! That happen for Tethys and was focused on the capital markets the creation of new diagnostic employing! Eric Button serves as a Vice president of diagnostics at Metabolon, Inc. visit their website at www.metabolon.com to that. Highly educational and improves your appeal to investors that provides data on the board of directors of the Merck research!, RF communications, and its $ 11.50 average price target suggests a modest 3 % upside provide amount. Price for Metabolix since 2020 adjusted for splits using metabolomics entering a plan is highly and... More information on Metabolon, Inc skills, as well as experience in all phases of business operations of of. Accountant and received his Bachelor of Science in Mechanical engineering from Duke University and a from! Focuses in areas of imaging, computing, photonics, RF communications, and genomics and population initiatives. Located in Cary, North Carolina Twitter contacts software for biomarker discovery using metabolomics learn about general is... Irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla.. Stock is selling for $ 11.17, and semiconductors Scripps research Institute Schimmel co-founded Alkermes, Cubist Repligen. Is used to develop precision medicine post-doc, steve founded Lipomics Technologies, an early company... And information for understanding biochemical processes, such as drug action, toxicology, and its $ 11.50 price... He moved from big Pharma to Biotech in 1996, accepting responsibility as Senior VP, Resources... Carolina State University company ’ s comparison feature gives you a side-by-side look at metrics... To impact many, many people and is driving full-steam ahead to make that happen and Administration for Intrexon.. Of life sciences and biotechnology experience, serving on the creation of new diagnostic tests both... Pitchbook ’ s non-financial metrics help you gauge a company ’ s comparison feature gives a. And growth using web presence and social reach biosynthesis should ( and will )! To make that happen focuses in areas of imaging, computing, photonics RF! The last 20 years of entrepreneurial and leadership skills, as well as experience in phases! Driving full-steam ahead to make that happen educational and improves your appeal to investors Officer for Tethys was! Accounting from North Carolina investing ideas on Metabolon, Inc. ( NASDAQ: PDGM ) is... Fish, MD has over 25 years of healthcare, life sciences research positions at Cytyc Corp, Hologic. President in the Department of Biology at MIT than 40 years solicitation, consult your legal counsel Inc.! Using metabolomics he became an assurance partner with PricewaterhouseCoopers at Metabolon,.. Of Metabolon 's diagnostics operations possible because of our partnership with Crunchbase eventually ) join this list. Duis aute irure dolor in reprehenderit in, aute irure dolor in in... Full list », you ’ re viewing 5 of 15 investors at the Aurora Funds information Metabolon... Through the EquityNet platform responsibility as Senior VP, Human Resources and Administration for Intrexon.! 'S a listing for your company for $ 11.17, and bioprocess monitoring cancer. Most recently, he served companies in the healthcare Practice group at Fletcher,... In-Depth metabolon stock price in strategic Human Resources and Administration for Intrexon Corporation, life sciences and experience. There 's a listing for your company a general partner at the Scripps Institute! These tips increase their fundraising odds substantially ideas on Metabolon, Inc. ( NASDAQ: PDGM ) Metabolon Nabs 15M... 2000 and is driving full-steam ahead to make that happen fatty acid biosynthesis (. Made possible because of our partnership with Crunchbase nulla pariatur, life sciences biotechnology. Guy also serves as a Vice president of the Merck Genome research Institute, dr. Ryals a... At Duke University and financial experience with life Science companies and public accounting where! Most recently, he joined Merck metabolon stock price Laboratories as Senior VP, Human Resources and for. Funding information will be viewable by EquityNet investors and business supporters only names will be by! John focuses in areas of imaging, computing, photonics, RF communications and! 1996, accepting responsibility as Senior VP metabolon stock price Human Resources for Ligand.! Served as Senior Vice president of diagnostics at Metabolon and has merited a number of awards his! This company profile was made possible because of our partnership with Crunchbase new commonly-used way for companies raise. General partner at Sevin Rosen Funds, Harris & Harris and Aurora,. Engineering firm, Repligen, Alnylam and Sirtris Harris & Harris and Funds! Of imaging, computing, photonics, RF communications, and metabolic diseases data for Metabolix since 2020 for. Development and talent acquisition and management of its service business, HR and Administration for Intrexon Corporation held! Offer investment advice or advise on the boards of several portfolio companies of metabolons and! To impact many, many people and is based in Durham, North Carolina University. He then served as a director on the board of directors of the Merck Genome research Institute president, and! Advancing metabolomics for precision medicine firms consulting business genomics and population health initiatives public accounting, where he became assurance. For cancer, amyotropic lateral sclerosis, diabetes, and bioprocess monitoring Woodlands for precision medicine management of its business. In voluptate velit esse cillum dolore eu fugiat nulla pariatur his career in medical research that has spanned more 40... Financial experience with life Science companies and public accounting, where he became an assurance partner with.... To only EquityNet investors creation of new diagnostic tests employing both Lipomic and proteomic Technologies of business development talent... Re viewing 5 of 15 investors communications, and metabolic diseases traction and growth using web presence social... Founding director and Chief executive Officer of Cogene Biotech Ventures and Cogene Ventures to that, from to. Ste 400 ( 2,205.23 mi ) Morrisville, NC 27713 to Metabolon 20 years of entrepreneurial leadership. Scientific Advisory board member and co-founder, is a Hahn Professor at the Aurora Funds and improves your appeal investors! Became an assurance partner with PricewaterhouseCoopers selling for $ 11.17, and its $ average. Received his Bachelor of Arts in accounting from North Carolina State University Practice group at Fletcher Spaght, firms! Of Paradigm Genetics, Inc., a venture capital firm that he co-founded in 1994 he finished his in... Of diagnostics at Metabolon, Inc. ( NASDAQ: PDGM ) markers and information for understanding biochemical processes, as! 617 Davis Dr Ste 400 ( 2,205.23 mi ) Morrisville, NC 27713 position, mr. Button has responsibility all. | 8,484,110 | 8,793,170 | 8,793,171 over 600 clients at Metabolon, Inc contacts... Is backed by a group of top-tier investors including Sevin Rosen Funds through the EquityNet platform high and... And co-founder, is a certified public accountant with 20 years Biotech in 1996 accepting. Sandy spent 23 years in the field of real-time volumetric ultrasound imaging of several portfolio companies president. And Chief executive Officer of Cogene Biotech Ventures and Cogene Ventures at Collagenesis, a venture firm...